Industry demands clarification of cost effectiveness criterion in making Medicare coverage decisions
This article was originally published in Clinica
Executive Summary
The US Medical Device Manufacturers Association (MDMA) urged the Health Care Financing Administration (HCFA) to discuss at a public meeting the role of cost-effectiveness in making decisions on whether or not to cover a procedure under the Medicare health insurance programme for the elderly. HCFA held a meeting last September to discuss its proposals for coverage reform.